DK1167354T3 - Racemisk huperzin A - Google Patents

Racemisk huperzin A

Info

Publication number
DK1167354T3
DK1167354T3 DK01203687T DK01203687T DK1167354T3 DK 1167354 T3 DK1167354 T3 DK 1167354T3 DK 01203687 T DK01203687 T DK 01203687T DK 01203687 T DK01203687 T DK 01203687T DK 1167354 T3 DK1167354 T3 DK 1167354T3
Authority
DK
Denmark
Prior art keywords
racemic
hypersensitivity
medicament
huperzine
cholesterase
Prior art date
Application number
DK01203687T
Other languages
English (en)
Inventor
Alain P Kozikowski
Yan Xia
Original Assignee
Mayo Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation filed Critical Mayo Foundation
Application granted granted Critical
Publication of DK1167354T3 publication Critical patent/DK1167354T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
DK01203687T 1989-02-21 1990-02-21 Racemisk huperzin A DK1167354T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/313,118 US4929731A (en) 1989-02-21 1989-02-21 Method for the synthesis of huperzine A and analogs thereof and compounds useful therein

Publications (1)

Publication Number Publication Date
DK1167354T3 true DK1167354T3 (da) 2003-09-01

Family

ID=23214460

Family Applications (2)

Application Number Title Priority Date Filing Date
DK01203687T DK1167354T3 (da) 1989-02-21 1990-02-21 Racemisk huperzin A
DK90904089T DK0460062T3 (da) 1989-02-21 1990-02-21 Huperzin A-analoger

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK90904089T DK0460062T3 (da) 1989-02-21 1990-02-21 Huperzin A-analoger

Country Status (10)

Country Link
US (1) US4929731A (da)
EP (3) EP0460062B1 (da)
JP (1) JP2933386B2 (da)
AT (3) ATE330943T1 (da)
CA (2) CA2047744C (da)
DE (3) DE69034226T2 (da)
DK (2) DK1167354T3 (da)
ES (2) ES2194003T3 (da)
HK (1) HK1030604A1 (da)
WO (1) WO1990009993A2 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177082A (en) * 1985-11-05 1993-01-05 Yu Chao Mei Huperzines and analogs
US5104880A (en) * 1991-05-01 1992-04-14 Mayo Foundation For Medical Education And Research Huperzine a analogs as acetylcholinesterase inhibitors
US5206393A (en) * 1991-09-30 1993-04-27 Union Carbide Chemicals & Plastics Technology Corporation Oxa-bicyclic polyfunctional compounds and preparation thereof
US5145973A (en) * 1991-09-30 1992-09-08 Union Carbide Chemicals & Plastics Technology Corporation Oxa-Bicyclic polyfunctional compounds and preparation thereof
US5547960A (en) * 1994-09-07 1996-08-20 Mayo Foundation For Medical Education And Research C-10 analogs of huperzine a
USRE38460E1 (en) 1994-12-28 2004-03-09 Shanghai Institute Of Materia Medica Chinese Academy Of Sciences Huperzine A derivatives, their preparation and their use
CN1125725A (zh) * 1994-12-28 1996-07-03 中国科学院上海药物研究所 一类海克林碱衍生物及它的用途
WO2001000215A1 (en) * 1999-06-25 2001-01-04 Wake Forest University Compositions for treating or preventing neurodegeneration and cognitive decline
US6271379B1 (en) 2000-03-08 2001-08-07 Georgetown University Intermediates useful for the synthesis of huperzine A
US6436972B1 (en) 2000-04-10 2002-08-20 Dalhousie University Pyridones and their use as modulators of serine hydrolase enzymes
US6369052B1 (en) 2000-08-07 2002-04-09 Georgetown University Combination of huperzine and nicotinic compounds as a neuroprotective agent
KR100390777B1 (ko) * 2000-12-19 2003-07-10 한국화학연구원 피리돈 유도체의 제조방법
US6967206B2 (en) 2002-12-05 2005-11-22 Access Business Group International Llc Compositions and methods for increasing growth hormone levels
EP1901733B1 (en) 2005-05-23 2016-04-06 President and Fellows of Harvard College Huperzine for use in the treatment of neuropathic pain
US8097726B2 (en) * 2006-05-17 2012-01-17 Industrial Technology Research Institute Huperzine a compound for treatment of alzheimer's disease
US20090247754A1 (en) * 2008-03-25 2009-10-01 Debiopharm S.A. Method of preparing huperzine a and derivatives thereof
WO2010028134A2 (en) * 2008-09-04 2010-03-11 President And Fellows Of Harvard College Treatment of neurological disorders using huperzine
CN104496900A (zh) * 2014-12-15 2015-04-08 陕西嘉禾植物化工有限责任公司 一种2-甲氧基-6-酮-5,7,8-三氢-喹啉的制备方法
CN104496998B (zh) * 2014-12-15 2017-07-11 陕西嘉禾生物科技股份有限公司 一种1′‑苄基‑2′‑酮‑5′，7′，8′‑三氢‑螺‑[1，3‑二氧五环‑2]‑喹啉的制备方法
CN109705038B (zh) * 2017-10-25 2020-11-03 广州市朗启医药科技有限责任公司 石杉碱甲的合成方法
CN114716449B (zh) * 2022-04-12 2023-09-29 浙江工业大学 一种2-甲氧基-6-乙二醇缩酮-5,7,8-三氢喹啉的制备方法

Also Published As

Publication number Publication date
DE69034226D1 (de) 2006-08-03
DE69034226T2 (de) 2007-06-21
EP0460062A1 (en) 1991-12-11
ES2173858T3 (es) 2002-11-01
EP1026157B1 (en) 2006-06-21
DE69034070T2 (de) 2003-12-18
ATE330943T1 (de) 2006-07-15
EP0460062A4 (en) 1992-07-01
DE69034070D1 (de) 2003-06-12
EP1167354B1 (en) 2003-05-07
EP1026157A2 (en) 2000-08-09
ATE239709T1 (de) 2003-05-15
EP1167354A2 (en) 2002-01-02
JP2933386B2 (ja) 1999-08-09
DK0460062T3 (da) 2002-08-26
DE69033970D1 (de) 2002-07-18
DE69033970T2 (de) 2002-10-02
ES2194003T3 (es) 2003-11-16
ATE219061T1 (de) 2002-06-15
EP0460062B1 (en) 2002-06-12
WO1990009993A2 (en) 1990-09-07
CA2047744C (en) 2000-05-02
CA2296915A1 (en) 1990-08-22
WO1990009993A3 (en) 1990-11-01
EP1026157A3 (en) 2004-08-11
US4929731A (en) 1990-05-29
EP1167354A3 (en) 2002-01-09
CA2047744A1 (en) 1990-08-22
HK1030604A1 (en) 2001-05-11

Similar Documents

Publication Publication Date Title
DK1167354T3 (da) Racemisk huperzin A
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
DE69011353T2 (de) Oral anzuwendende antifungale Arzneizubereitungen.
UA26303A1 (uk) Фармацевтичhа композиція, яка має імуhосупресорhу та аhтимікробhу активhість
SE9504661D0 (sv) New compounds
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
EE02962B1 (et) Mometasoonfuroaadi monohüdraat, selle valmistamismeetod ja farmatseutilised kompositsioonid
ATE218581T1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
KR930701456A (ko) 세팔로스포린 및 동족체, 제조 및 제약학적 조성물
SE9201628D0 (sv) Pharmaceutical composition
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
IT1230703B (it) Derivati imidazolonici ad attivita' antiipertensiva, loro metodi di preparazione e composizioni farmaceutiche che li contengono.
AU563831B2 (en) N-(2-amino-3,5-dibromobenzyl)- trans-4-amino-cyclohexanol derivatives
MA19882A1 (fr) Derives d'acides w-amines, leur preparation et utilisation ainsi que les compositions contenant ces acides.
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
SE9504662D0 (sv) New compounds
DE60039122D1 (de) 6-o-alkyl-2-nor-2-substituierte ketolidderivate
ATE102934T1 (de) Fluorierte flavon-essigsaeure.
YU2394A (sh) Lizin so 6-hloro-5-fluoro-3-(-2-tenoil)-2-oksindol-1-karboksamida
PT99238A (pt) Processo para a preparacao de composicoes farmaceuticas contendo um inibidor da enzima conversora da angiotensina e um inibidor da actividade do tromboxano a2, utilizadas no tratamento de nefropatias
KR960021044A (ko) 세코노가노사이드를 포함하는 b형 간염 치료제
IT8919204A0 (it) Composizione per la prevenzione e la cura di parodontopatte.
ITMI922832A1 (it) DERIVATI DELL'ESEROLINA AD ATTIVITAy ANTICOLINESTERASICA, PROCEDIMENTO PER LA LORO PREPARAZIONE E COMPOSIZIONI FARMACEUTICHE CHE LI CONTENGONO.